Alayev A - Search Results

1

Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells.

Li C, Liu X, Liu Y, Zhang E, Medepalli K, Masuda K, Li N, Wikenheiser-Brokamp KA, Osterburg A, Borchers MT, Kopras EJ, Plas DR, Sun J, Franz DN, Capal JK, Mays M, Sun Y, Kwiatkowski DJ, Alayev A, Holz MK, Krueger DA, Siroky BJ, Yu JJ. Li C, et al. Among authors: alayev a. Mol Cancer Res. 2017 Oct;15(10):1318-1330. doi: 10.1158/1541-7786.MCR-17-0077. Epub 2017 Jul 14. Mol Cancer Res. 2017. PMID: 28710231

2

mTOR signaling for biological control and cancer.

Alayev A, Holz MK. Alayev A, et al. J Cell Physiol. 2013 Aug;228(8):1658-64. doi: 10.1002/jcp.24351. J Cell Physiol. 2013. PMID: 23460185 Free PMC article. Review.

3

Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.

Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK. Alayev A, et al. Cell Cycle. 2014;13(3):371-82. doi: 10.4161/cc.27355. Epub 2013 Dec 4. Cell Cycle. 2014. PMID: 24304514 Free PMC article.

4

Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling.

Alayev A, Doubleday PF, Berger SM, Ballif BA, Holz MK. Alayev A, et al. J Proteome Res. 2014 Dec 5;13(12):5734-42. doi: 10.1021/pr500714a. Epub 2014 Oct 29. J Proteome Res. 2014. PMID: 25311616 Free PMC article.

5

The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.

Alayev A, Berger SM, Kramer MY, Schwartz NS, Holz MK. Alayev A, et al. J Cell Biochem. 2015 Mar;116(3):450-7. doi: 10.1002/jcb.24997. J Cell Biochem. 2015. PMID: 25336146 Free PMC article.

6

Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.

Alayev A, Salamon RS, Sun Y, Schwartz NS, Li C, Yu JJ, Holz MK. Alayev A, et al. Am J Respir Cell Mol Biol. 2015 Nov;53(5):637-46. doi: 10.1165/rcmb.2015-0022OC. Am J Respir Cell Mol Biol. 2015. PMID: 25844891 Free PMC article.

7

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

Alayev A, Berger SM, Holz MK. Alayev A, et al. Ann N Y Acad Sci. 2015 Aug;1348(1):116-23. doi: 10.1111/nyas.12829. Epub 2015 Jul 22. Ann N Y Acad Sci. 2015. PMID: 26200935 Review.

8

mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.

Alayev A, Salamon RS, Berger SM, Schwartz NS, Cuesta R, Snyder RB, Holz MK. Alayev A, et al. Oncogene. 2016 Jul 7;35(27):3535-43. doi: 10.1038/onc.2015.414. Epub 2015 Nov 2. Oncogene. 2016. PMID: 26522726 Free PMC article.

9

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.

Manna S, Bostner J, Sun Y, Miller LD, Alayev A, Schwartz NS, Lager E, Fornander T, Nordenskjöld B, Yu JJ, Stål O, Holz MK. Manna S, et al. Among authors: alayev a. Clin Cancer Res. 2016 Mar 15;22(6):1421-31. doi: 10.1158/1078-0432.CCR-15-0857. Epub 2015 Nov 5. Clin Cancer Res. 2016. PMID: 26542058 Free PMC article.

10

Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.

Alayev A, Salamon RS, Schwartz NS, Berman AY, Wiener SL, Holz MK. Alayev A, et al. J Cell Physiol. 2017 Feb;232(2):436-446. doi: 10.1002/jcp.25443. Epub 2016 Jun 10. J Cell Physiol. 2017. PMID: 27225870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters